Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Thyroid : Official Journal of the American Thyroid Association|September 10, 2020
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid CancerCarlotta Giani, Laura Valerio, Alberto Bongiovanni, et al.
Cancers|August 27, 2021
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer PatientsAnna Cavallo, Nicola Alessandro Iacovelli, Nadia Facchinetti, et al.
Future Oncology (London, England)|December 21, 2012
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinomaEster Orlandi, Stefano Tomatis, Paolo Potepan, et al.
Frontiers in Oncology|December 17, 2021
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative ReviewPierre Loap, Barbara Vischioni, Maria Bonora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinomaFederica Perrone, Simona Suardi, Elisa Pastore, et al.
Oral Oncology|January 18, 2016
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?Cristiana Bergamini, Laura Locati, Paolo Bossi, et al.
Thyroid : Official Journal of the American Thyroid Association|April 11, 2022
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid CancerJaume Capdevila, Arkadiy Klochikhin, Sophie Leboulleux, et al.
The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
Frontiers in Oncology|October 19, 2020
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer PatientsNicola Alessandro Iacovelli, Alessandro Cicchetti, Anna Cavallo, et al.
Cancers|October 17, 2020
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma PatientsMarco Bologna, Valentina Corino, Giuseppina Calareso, et al.
Pageof 5